Sunbelt Securities’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24 Buy
+3
New +$27 ﹤0.01% 2861
2025
Q4
Sell
-200
Closed -$1.73K 2901
2025
Q3
$1.73K Buy
+200
New +$1.56K ﹤0.01% 1912
2025
Q2
Sell
-200
Closed -$1.28K 1868
2025
Q1
$1.28K Buy
+200
New +$1.65K ﹤0.01% 1625
2023
Q4
Sell
-10
Closed -$72 1760
2023
Q3
$72 Hold
10
﹤0.01% 1736
2023
Q2
$74 Hold
10
﹤0.01% 1668
2023
Q1
$66 Buy
+10
New +$92 ﹤0.01% 1619

Other funds holding NVAX

Sunbelt Securities's NVAX Position: Q1 2026 in Review

Sunbelt Securities opened a new position in Novavax (NVAX) in Q1 2026: 3 shares worth $24. The stake represents ﹤0.01% of the portfolio and ranks #2861 among its holdings. This is a return to the name: Sunbelt Securities previously reported a position in NVAX as recently as Q3 2025.

Sunbelt Securities first reported a position in NVAX in Q1 2023 and has held it in 6 quarters since. The position peaked at $1.73K in Q3 2025. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Sunbelt Securities held 3 shares of Novavax worth $24 as of Q1 2026.
  • Novavax was a new Sunbelt Securities position in Q1 2026.
  • Novavax made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2861 holding.
  • Sunbelt Securities first reported a position in Novavax in Q1 2023 and has held it in 6 quarters since.
  • Sunbelt Securities's Novavax position peaked at $1.73K in Q3 2025.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.